- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04738721
Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown
May 4, 2021 updated by: Gülay Aras, Medipol University
Comparison of Physical Activity and Physical Fitness Parameters Pre and Post COVID-19 Lockdown in Young Adults
In this study; it was aimed to compare the physical activity levels of students who continued their university education face-to-face before the COVID-19 lockdown, and the values of physical activity levels related to health, physical activity levels and health-related physical fitness parameters in the post-lockdown period.
Study Overview
Detailed Description
Within the scope of the course, the demographic information of the students will be recorded and physical activity status, physical fitness parameters, muscle endurance, cardiovascular endurance, flexibility and body composition will be evaluated.
Study Type
Observational
Enrollment (Actual)
79
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul Medipol University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 22 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Students of university
Description
Inclusion Criteria:
- Before the quarantine period, those who completed the physical activity level and physical fitness tests within the scope of Physical Activity I course
- Students who do not have any physical or mental problems for the tests and measurements to be applied
Exclusion Criteria:
- No internet access,
- Students who have an obstacle to taking tests and measurements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical activity
Time Frame: 2 days
|
International Physical Activity Questionnaire Short Form
|
2 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical fitness
Time Frame: 2 days
|
6 Minute Walk Test
|
2 days
|
Flexibility
Time Frame: 2 days
|
Sit-Rise Test
|
2 days
|
Body composition
Time Frame: 2 days
|
Body fat ratio
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Pınar Kaya Ciddi, PhD, Medipol University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 5, 2021
Primary Completion (Actual)
April 4, 2021
Study Completion (Actual)
May 4, 2021
Study Registration Dates
First Submitted
February 1, 2021
First Submitted That Met QC Criteria
February 2, 2021
First Posted (Actual)
February 4, 2021
Study Record Updates
Last Update Posted (Actual)
May 5, 2021
Last Update Submitted That Met QC Criteria
May 4, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- E-10840098-772.02-2685
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Assessment, Self
-
University Hospital Inselspital, BerneCompletedSelf-AssessmentSwitzerland
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingHealthy | Assessment, Self
-
Johannes Kepler University of LinzMedical University of GrazRecruiting
-
Johannes Kepler University of LinzMedical University of GrazCompleted
-
Technical University of MunichCharite University, Berlin, Germany; Translationales intensivmedizinisches...CompletedCritical Illness | Assessment, Self | Self-AssessmentGermany
-
AdventHealthUniversity of South Florida; Yale University; Beth Israel Deaconess Medical Center and other collaboratorsActive, not recruitingAssessment, Self | CompetenceUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedBody Image | Assessment, SelfTurkey
-
Lund UniversityCompletedCopd | Hospitalization | Assessment, SelfSweden
-
Universidad Católica San Antonio de MurciaCompletedAssessment, Self | Clinical PerformanceSpain
Clinical Trials on Evaluation
-
IRCCS Eugenio MedeaCompletedIntellectual Disability | Autism Spectrum Disorder | Attention Deficit Hyperactivity DisorderItaly
-
University Hospital, BordeauxRoche Pharma AGRecruitingMultiple Sclerosis, Primary ProgressiveFrance
-
University Hospital, BordeauxRecruitingMultiple SclerosisFrance
-
University Hospital, CaenRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Motoric Cognitive Risk SyndromeFrance
-
University of CatanzaroAzienda Sanitaria Provinciale Di Catanzaro; Azienda Ospedaliera Universitaria...Unknown
-
Ankara Yildirim Beyazıt UniversityCompletedType 2 Diabetes Mellitus | BalanceTurkey
-
Wake Forest University Health SciencesAgency for Healthcare Research and Quality (AHRQ)Recruiting
-
Kırıkkale UniversityCompleted
-
Institut National de la Santé Et de la Recherche...Terminated